Martin Wilhelm Kurz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Martin Wilhelm Kurz has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
- Kathinka Dæhli Kurz
Stavanger Medical Imaging Laboratory, Department of Radiology, Stavanger University Hospital, Stavanger, Norway
9 shared publications - Ingvild Dalen
Department of Research, Stavanger University Hospital, Stavanger, Norway
6 shared publications - Mehdi K. Rezai
Department of Neurology and Neuroscience Research Group, Stavanger University Hospital , Stavanger
4 shared publications - Jan Larsen
The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway
3 shared publications - Rajiv Advani
Stroke Unit, Department of Neurology, Oslo University Hospital, Oslo, Norway
3 shared publications - Soffien Chadli Ajmi
Department of Neurology and Neuroscience Research Group, Stavanger University Hospital , 4068 Stavanger
3 shared publications
Latest Publications
- Open Access
- 2 June 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (6)
Regional inequities in acute stroke care in Norway: a national benchmark for the “stroke action plan for Europe” implementation
Introduction: The Stroke Action Plan for Europe (SAP-E) calls for equitable access to evidence-based acute stroke care, yet within-country variation remains underexplored. We mapped reperfusion capabilities, imaging resources and organisational structures across all Norwegian hospitals providing acute stroke care. Patients and methods: In 2024, we conducted a cross-sectional survey of all 50 acute stroke hospitals. Data covered reperfusion protocols, advanced imaging availability and the organisational maturity of regional stroke networks. Hospitals were categorised by their most advanced routinely available strategy: intravenous thrombolysis (IVT) within 0–4.5 h (IVT ≤ 4.5 h); IVT in wake-up stroke; IVT in both wake-up stroke and the extended window or endovascular thrombectomy (EVT) capability. Results: All hospitals providing local acute stroke treatment offered IVT ≤ 4.5 h, while 3 hospitals in South-Eastern Norway had a stroke unit but transferred all acute patients directly to a comprehensive stroke centre. Eleven hospitals (22%) provided IVT ≤ 4.5 h only, 8 (16%) implemented IVT for wake-up stroke and 28 (56%) offered IVT for both wake-up and extended-window thrombolysis. Eight hospitals (16%) were EVT-capable, unevenly distributed. CT perfusion (CTP) was available in 28 hospitals (56%), and acute MRI in 17 (34%). Regional stroke networks varied widely in structure and activity, from well-organised, funded systems to inactive or absent networks. Conclusion: Norway shows universal IVT access within 0–4.5 h but marked regional variation in advanced treatment, imaging and coordination. Strengthening and standardising regional stroke networks may be key to achieving SAP-E’s vision of equitable, high-quality care.
- 2 June 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (6)
Open AccessRegional inequities in acute stroke care in Norway: a national benchmark for the “stroke action plan for Europe” implementation
Introduction: The Stroke Action Plan for Europe (SAP-E) calls for equitable access to evidence-based acute stroke care, yet within-country variation remains underexplored. We mapped reperfusion capabilities, imaging resources and organisational structures across all Norwegian hospitals providing acute stroke care. Patients and methods: In 2024, we conducted a cross-sectional survey of all 50 acute stroke hospitals. Data covered reperfusion protocols, advanced imaging availability and the organisational maturity of regional stroke networks. Hospitals were categorised by their most advanced routinely available strategy: intravenous thrombolysis (IVT) within 0–4.5 h (IVT ≤ 4.5 h); IVT in wake-up stroke; IVT in both wake-up stroke and the extended window or endovascular thrombectomy (EVT) capability. Results: All hospitals providing local acute stroke treatment offered IVT ≤ 4.5 h, while 3 hospitals in South-Eastern Norway had a stroke unit but transferred all acute patients directly to a comprehensive stroke centre. Eleven hospitals (22%) provided IVT ≤ 4.5 h only, 8 (16%) implemented IVT for wake-up stroke and 28 (56%) offered IVT for both wake-up and extended-window thrombolysis. Eight hospitals (16%) were EVT-capable, unevenly distributed. CT perfusion (CTP) was available in 28 hospitals (56%), and acute MRI in 17 (34%). Regional stroke networks varied widely in structure and activity, from well-organised, funded systems to inactive or absent networks. Conclusion: Norway shows universal IVT access within 0–4.5 h but marked regional variation in advanced treatment, imaging and coordination. Strengthening and standardising regional stroke networks may be key to achieving SAP-E’s vision of equitable, high-quality care.
- Open Access
- 7 July 2025
- Published by BMJ in BMJ Open Quality
- Vol. 14 (3) , e002981
Unveiling team needs: a qualitative study of simulation training for endovascular cerebral thrombectomy
Background: Effective multidisciplinary teamwork is crucial for successful endovascular thrombectomy (EVT) treatment, a critical stroke intervention classified as a non-operating room anaesthesia (NORA) procedure. Our hospital incorporated EVT training into regular stroke simulation training. This study aimed to investigate team members’ experiences of simulation training in preparation for clinical EVT, including how the training and related clinical procedures could be improved to address their identified needs. Methods: Six focus group interviews (one anaesthesia-only professional, five mixed healthcare professionals) were conducted with a purposeful sample of EVT team members. The data were analysed using inductive qualitative content analysis. Results: EVT team members considered simulation training an essential introduction to the clinical procedure, particularly for familiarisation with the angio suite, equipment, team roles and communication. However, they reported that the simulation did not prepare them for challenges inherent to NORA procedures encountered during clinical EVT. These included managing multidisciplinary task interactions, maintaining haemodynamic and respiratory stability, and working within spatial and access constraints. Consequently, the experience of disorganised teamwork persisted in clinical EVT. The team members reported a lack of shared understanding of roles, responsibilities and communication expectations, particularly between anaesthesia professionals and other team members. This contributed to unfamiliarity with team dynamics and workflow. The clinical EVT team leader inconsistently facilitated collaboration, impacting team communication and effectiveness. The participants proposed modifications to the simulation training and clinical procedure to address these issues. Conclusions: Our study highlights the need to incorporate the multidisciplinary challenges of NORA procedures into EVT simulation training, emphasising active input from all professional groups involved in the EVT team, particularly anaesthesia. Practical recommendations for planning and implementing such simulation training are proposed.
- 7 July 2025
- Published by BMJ in BMJ Open Quality
- Vol. 14 (3) , e002981
Open AccessUnveiling team needs: a qualitative study of simulation training for endovascular cerebral thrombectomy
Background: Effective multidisciplinary teamwork is crucial for successful endovascular thrombectomy (EVT) treatment, a critical stroke intervention classified as a non-operating room anaesthesia (NORA) procedure. Our hospital incorporated EVT training into regular stroke simulation training. This study aimed to investigate team members’ experiences of simulation training in preparation for clinical EVT, including how the training and related clinical procedures could be improved to address their identified needs. Methods: Six focus group interviews (one anaesthesia-only professional, five mixed healthcare professionals) were conducted with a purposeful sample of EVT team members. The data were analysed using inductive qualitative content analysis. Results: EVT team members considered simulation training an essential introduction to the clinical procedure, particularly for familiarisation with the angio suite, equipment, team roles and communication. However, they reported that the simulation did not prepare them for challenges inherent to NORA procedures encountered during clinical EVT. These included managing multidisciplinary task interactions, maintaining haemodynamic and respiratory stability, and working within spatial and access constraints. Consequently, the experience of disorganised teamwork persisted in clinical EVT. The team members reported a lack of shared understanding of roles, responsibilities and communication expectations, particularly between anaesthesia professionals and other team members. This contributed to unfamiliarity with team dynamics and workflow. The clinical EVT team leader inconsistently facilitated collaboration, impacting team communication and effectiveness. The participants proposed modifications to the simulation training and clinical procedure to address these issues. Conclusions: Our study highlights the need to incorporate the multidisciplinary challenges of NORA procedures into EVT simulation training, emphasising active input from all professional groups involved in the EVT team, particularly anaesthesia. Practical recommendations for planning and implementing such simulation training are proposed.
- 4 October 2024
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 466, 123265
Thrombolysis in wake-up stroke based on MRI mismatch
- 4 October 2024
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 466, 123265
Thrombolysis in wake-up stroke based on MRI mismatch
- Open Access
Does clinical experience influence the effects of team simulation training in stroke thrombolysis? A prospective cohort study
Objectives After introducing a team simulation training programme at our hospital, we saw a reduction in door-to-needle times (DNT) for stroke thrombolysis but persisting variability prompting further investigation. Our objective is to examine this gap through assessing: (1) whether there is an association between DNT and the clinical experience of neurology registrars and (2) whether experience influences the benefits from attending simulation. Design Prospective cohort study. Setting and participants Patients treated with intravenous thrombolysis between January 2016 and 2020 at a Norwegian stroke centre. Primary and secondary outcome measures Using DNT and prior intravenous thrombolysis administrations (case-based definition of clinical experience) as continuous variables, a mixed effects linear regression model was performed to examine the association between clinical experience, DNT and simulation attendance. For dichotomised analyses, neurology registrars with 15 or more prior treatments were defined as experienced. Results A total of 532 patients treated by 36 neurology registrars from January 2016 to 2020 were included. There was a linear association between clinical experience and DNT (test for non-linearity p=0.479). Each prior intravenous thrombolysis administration was associated with a significant 1.1% decrease in DNT in the adjusted analysis (ΔDNT −1.1%; 95% CI, −2.2% to −0.0%; p=0.048). The interaction between effects of clinical experience and simulation on DNT was not statistically significant (p=0.150). In the dichotomised analysis, experienced registrars had similar gains from attending simulation sessions (mean DNT from 18.5 min to 13.5 min) compared with less experienced registrars (mean DNT from 22.4 min to 17.4 min). Conclusions Less experienced registrars had longer DNT in stroke thrombolysis. Attending team simulation training was associated with similar improvements for experienced and inexperienced neurology registrars. We suggest a focus on high-quality onboarding programmes to close the experience-related quality gap. Our findings suggest that both inexperienced and experienced neurology registrars might benefit from team simulation training for stroke thrombolysis.
Open AccessDoes clinical experience influence the effects of team simulation training in stroke thrombolysis? A prospective cohort study
Objectives After introducing a team simulation training programme at our hospital, we saw a reduction in door-to-needle times (DNT) for stroke thrombolysis but persisting variability prompting further investigation. Our objective is to examine this gap through assessing: (1) whether there is an association between DNT and the clinical experience of neurology registrars and (2) whether experience influences the benefits from attending simulation. Design Prospective cohort study. Setting and participants Patients treated with intravenous thrombolysis between January 2016 and 2020 at a Norwegian stroke centre. Primary and secondary outcome measures Using DNT and prior intravenous thrombolysis administrations (case-based definition of clinical experience) as continuous variables, a mixed effects linear regression model was performed to examine the association between clinical experience, DNT and simulation attendance. For dichotomised analyses, neurology registrars with 15 or more prior treatments were defined as experienced. Results A total of 532 patients treated by 36 neurology registrars from January 2016 to 2020 were included. There was a linear association between clinical experience and DNT (test for non-linearity p=0.479). Each prior intravenous thrombolysis administration was associated with a significant 1.1% decrease in DNT in the adjusted analysis (ΔDNT −1.1%; 95% CI, −2.2% to −0.0%; p=0.048). The interaction between effects of clinical experience and simulation on DNT was not statistically significant (p=0.150). In the dichotomised analysis, experienced registrars had similar gains from attending simulation sessions (mean DNT from 18.5 min to 13.5 min) compared with less experienced registrars (mean DNT from 22.4 min to 17.4 min). Conclusions Less experienced registrars had longer DNT in stroke thrombolysis. Attending team simulation training was associated with similar improvements for experienced and inexperienced neurology registrars. We suggest a focus on high-quality onboarding programmes to close the experience-related quality gap. Our findings suggest that both inexperienced and experienced neurology registrars might benefit from team simulation training for stroke thrombolysis.
- Open Access
- 24 August 2023
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 2023, 1-6
Volume and Visual Field Defects in Occipital Stroke: The NOR-OCCIP Study
Introduction. The majority of patients with occipital infarcts display homonymous visual field defects (VFD), with negative implications on activities of daily living and quality of life. To overcome the disability, better prognostic markers in the acute phase, as well as more targeted rehabilitation, would be useful. The aim of the current study was to present an overview of the topographic distribution of occipital infarcts and to investigate whether lesion volume can predict VFD at baseline and after six months. Materials and Methods. Multicenter, prospective study including patients with acute occipital infarcts (NOR-OCCIP project). All patients were examined by a neurologist in the acute phase, admitted to a stroke unit, and further assessed by an ophthalmologist within two weeks. Topographic and volumetric data from brain imaging in 72 patients were analyzed and computed by an experienced neuroradiologist. Results. A majority (81%) had occipital infarcts with involvement of the primary visual cortex, and VFD were detected on perimetry in 80% of the examined patients. Higher infarct volume led to more severe VFD at baseline ( ); this was more evident if the infarct was located on the right side ( ). The odds for VFD improvement after six months were higher the larger the infarcts were ( ). There was a statistically significant association between volume of infarcts and atrial fibrillation ( ), previous myocardial infarction ( ), and modified Rankin Scale at three months ( ). Conclusion. Higher infarct volumes led to more severe VFD at baseline. More than half of the patients (54%) experienced improvement of their VFD at six months; a higher grade of improvement was seen in patients with larger occipital infarcts. Large infarcts were more common in patients with cardiovascular disease, strengthening the argument for secondary prevention.
- 24 August 2023
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 2023, 1-6
Open AccessVolume and Visual Field Defects in Occipital Stroke: The NOR-OCCIP Study
Introduction. The majority of patients with occipital infarcts display homonymous visual field defects (VFD), with negative implications on activities of daily living and quality of life. To overcome the disability, better prognostic markers in the acute phase, as well as more targeted rehabilitation, would be useful. The aim of the current study was to present an overview of the topographic distribution of occipital infarcts and to investigate whether lesion volume can predict VFD at baseline and after six months. Materials and Methods. Multicenter, prospective study including patients with acute occipital infarcts (NOR-OCCIP project). All patients were examined by a neurologist in the acute phase, admitted to a stroke unit, and further assessed by an ophthalmologist within two weeks. Topographic and volumetric data from brain imaging in 72 patients were analyzed and computed by an experienced neuroradiologist. Results. A majority (81%) had occipital infarcts with involvement of the primary visual cortex, and VFD were detected on perimetry in 80% of the examined patients. Higher infarct volume led to more severe VFD at baseline ( ); this was more evident if the infarct was located on the right side ( ). The odds for VFD improvement after six months were higher the larger the infarcts were ( ). There was a statistically significant association between volume of infarcts and atrial fibrillation ( ), previous myocardial infarction ( ), and modified Rankin Scale at three months ( ). Conclusion. Higher infarct volumes led to more severe VFD at baseline. More than half of the patients (54%) experienced improvement of their VFD at six months; a higher grade of improvement was seen in patients with larger occipital infarcts. Large infarcts were more common in patients with cardiovascular disease, strengthening the argument for secondary prevention.
- Open Access
- 1 November 2022
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 146 (5) , 628-634
Thrombectomy in large vessel occlusion stroke-Does age matter?
Objectives Endovascular treatment (EVT) is the gold standard treatment for emergent large vessel occlusion (LVO). The benefit of EVT for emergent LVO in elderly patients (>80 years old) is still debated as they have been under-represented in randomized controlled trials. Elderly patients with an emergent LVO are a growing population warranting further study. Materials & Methods We included 225 consecutive patients treated with EVT for LVO either in the anterior or posterior circulation. The clinical outcome was assessed using the National Institute of Health Stroke Scale (NIHSS). Long-term functional outcome was assessed using 90-day modified ranking scale (mRS). Results Neurological improvement: A five-year higher age predicted a 0.43 higher mean NIHSS score after EVT (p = .027). After adjusting for confounders (influencing variables), the association between age and post-interventional NIHSS was reduced and non-significant (p = .17). At discharge, a five-year higher age predicted a 0.74 higher mean NIHSS (p = .003). After adjusting for confounders this association was reduced and non-significant (p = .06). Long-term functional outcome: A five-year higher age predicted a 0.20 higher mRS at three months (p < .001). When adjusting for confounders this number was reduced to 0.16, yet still highly significant (p < .001). Conclusions Age seems to have a minor role in predicting neurological improvement after EVT but has an impact on long-term functional outcome. The decision to perform or withhold EVT should therefore not solely be based on age.
- 1 November 2022
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 146 (5) , 628-634
Open AccessThrombectomy in large vessel occlusion stroke-Does age matter?
Objectives Endovascular treatment (EVT) is the gold standard treatment for emergent large vessel occlusion (LVO). The benefit of EVT for emergent LVO in elderly patients (>80 years old) is still debated as they have been under-represented in randomized controlled trials. Elderly patients with an emergent LVO are a growing population warranting further study. Materials & Methods We included 225 consecutive patients treated with EVT for LVO either in the anterior or posterior circulation. The clinical outcome was assessed using the National Institute of Health Stroke Scale (NIHSS). Long-term functional outcome was assessed using 90-day modified ranking scale (mRS). Results Neurological improvement: A five-year higher age predicted a 0.43 higher mean NIHSS score after EVT (p = .027). After adjusting for confounders (influencing variables), the association between age and post-interventional NIHSS was reduced and non-significant (p = .17). At discharge, a five-year higher age predicted a 0.74 higher mean NIHSS (p = .003). After adjusting for confounders this association was reduced and non-significant (p = .06). Long-term functional outcome: A five-year higher age predicted a 0.20 higher mRS at three months (p < .001). When adjusting for confounders this number was reduced to 0.16, yet still highly significant (p < .001). Conclusions Age seems to have a minor role in predicting neurological improvement after EVT but has an impact on long-term functional outcome. The decision to perform or withhold EVT should therefore not solely be based on age.
- Open Access
- 1 November 2021
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 12
Time-Based Decision Making for Reperfusion in Acute Ischemic Stroke
Decision making in the extended time windows for acute ischemic stroke can be a complex and time-consuming process. The process of making the clinical decision to treat has been compounded by the availability of different imaging modalities. In the setting of acute ischemic stroke, time is of the essence and chances of a good outcome diminish by each passing minute. Navigating the plethora of advanced imaging modalities means that treatment in some cases can be inefficaciously delayed. Time delays and individually based non-programmed decision making can prove challenging for clinicians. Visual aids can assist such decision making aimed at simplifying the use of advanced imaging. Flow charts are one such visual tool that can expedite treatment in this setting. A systematic review of existing literature around imaging modalities based on site of occlusion and time from onset can be used to aid decision making; a more program-based thought process. The use of an acute reperfusion flow chart helping navigate the myriad of imaging modalities can aid the effective treatment of patients.
- 1 November 2021
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 12
Open AccessTime-Based Decision Making for Reperfusion in Acute Ischemic Stroke
Decision making in the extended time windows for acute ischemic stroke can be a complex and time-consuming process. The process of making the clinical decision to treat has been compounded by the availability of different imaging modalities. In the setting of acute ischemic stroke, time is of the essence and chances of a good outcome diminish by each passing minute. Navigating the plethora of advanced imaging modalities means that treatment in some cases can be inefficaciously delayed. Time delays and individually based non-programmed decision making can prove challenging for clinicians. Visual aids can assist such decision making aimed at simplifying the use of advanced imaging. Flow charts are one such visual tool that can expedite treatment in this setting. A systematic review of existing literature around imaging modalities based on site of occlusion and time from onset can be used to aid decision making; a more program-based thought process. The use of an acute reperfusion flow chart helping navigate the myriad of imaging modalities can aid the effective treatment of patients.
- 1 July 2020
- Published by Wolters Kluwer Health in Stroke
- Vol. 51 (7) , 1978-1982
Simulation Methods in Acute Stroke Treatment
- 1 July 2020
- Published by Wolters Kluwer Health in Stroke
- Vol. 51 (7) , 1978-1982
Simulation Methods in Acute Stroke Treatment
- 8 June 2020
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 142 (5) , 475-479
Clinical outcomes and safety profile of Tenecteplase in wake‐up stroke
Background Tenecteplase has probably pharmacological and clinical advantages in the treatment of acute ischemic stroke. There are lacking data about safety and efficacy of tenecteplase in wake‐up stroke (WUPS). Aims To investigate safety and efficacy of tenecteplase compared to alteplase in WUPS patients included in NOR‐TEST. Methods WUPS patients in NOR‐TEST were included in the study based on DWI‐FLAIR mismatch. Included patients randomly assigned (1:1) to receive intravenous tenecteplase 0.4 mg/kg (to a maximum of 40 mg) or alteplase 0.9 mg/kg (to a maximum of 90 mg). Neurological improvement was defined as 1) favorable functional outcome at 90 days modified Rankin Scale (mRS) of 0 or 1 and 2) neurological improvement measured with the National Institutes of Health Stroke Scale (NIHSS) of 4 points within 24 hours as compared to admission NIHSS or NIHSS 0 at 24 hours. Results Of 1100 patients from 13 stroke centers included in NOR‐TEST, 45 were WUPS patients. Of these, 5 patients were stroke mimics and excluded. Of the remaining 40 patients (3.6%), 24 were treated with alteplase (60%). There was no difference in the number of patients achieving a good clinical outcome (mRS 0‐1) in either treatment group. Patients treated with tenecteplase showed a better early neurological improvement (87.5% vs 54.2%, P = 0.027). No ICH was detected on MRI/CT 24‐28 hours after thrombolysis. Conclusions In WUPS patients treated in NOR‐TEST, there was no difference in clinical outcomes at 90 days and no ICH events or deaths were observed in either alteplase‐ or tenecteplase‐treated patients. Clinical Trial Registration—URL: https://www.clinicaltrials.gov. Unique identifier: NCT01949948.
- 8 June 2020
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 142 (5) , 475-479
Clinical outcomes and safety profile of Tenecteplase in wake‐up stroke
Background Tenecteplase has probably pharmacological and clinical advantages in the treatment of acute ischemic stroke. There are lacking data about safety and efficacy of tenecteplase in wake‐up stroke (WUPS). Aims To investigate safety and efficacy of tenecteplase compared to alteplase in WUPS patients included in NOR‐TEST. Methods WUPS patients in NOR‐TEST were included in the study based on DWI‐FLAIR mismatch. Included patients randomly assigned (1:1) to receive intravenous tenecteplase 0.4 mg/kg (to a maximum of 40 mg) or alteplase 0.9 mg/kg (to a maximum of 90 mg). Neurological improvement was defined as 1) favorable functional outcome at 90 days modified Rankin Scale (mRS) of 0 or 1 and 2) neurological improvement measured with the National Institutes of Health Stroke Scale (NIHSS) of 4 points within 24 hours as compared to admission NIHSS or NIHSS 0 at 24 hours. Results Of 1100 patients from 13 stroke centers included in NOR‐TEST, 45 were WUPS patients. Of these, 5 patients were stroke mimics and excluded. Of the remaining 40 patients (3.6%), 24 were treated with alteplase (60%). There was no difference in the number of patients achieving a good clinical outcome (mRS 0‐1) in either treatment group. Patients treated with tenecteplase showed a better early neurological improvement (87.5% vs 54.2%, P = 0.027). No ICH was detected on MRI/CT 24‐28 hours after thrombolysis. Conclusions In WUPS patients treated in NOR‐TEST, there was no difference in clinical outcomes at 90 days and no ICH events or deaths were observed in either alteplase‐ or tenecteplase‐treated patients. Clinical Trial Registration—URL: https://www.clinicaltrials.gov. Unique identifier: NCT01949948.
- 13 April 2020
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 142 (2) , 169-174
Endovascular thrombectomy at low‐volume centres: A Bayesian solution
Purpose Endovascular treatment (EVT) is traditionally performed by neurointerventional radiologists at tertiary medical centres imposing long transport ways to large vessel occlusion (LVO) stroke patients in rural areas. The purpose of this study is to evaluate the technical and clinical results over time at Stavanger University Hospital, a hospital without neurointerventional expertise, where trained general interventional radiologist perform EVT. Methods All patients with LVO stroke treated with EVT from May 2009 to December 2018 were included in the analysis. Technical outcome was measured by the modified treatment in cerebral ischemia (mTICI) score, functional outcome by the modified Rankin scale (mRS), complications registered. Results 235 patients were treated with EVT. An angiographically good result (mTICI 2b or 3) could be seen in 66.7% of the patients treated the first year. In 2011, the year EVT with stent retrievers was introduced, the recanalization rate rose to 81.8% and from 2014 onwards it was stable around 80%. After introduction of aspiration together with stent retrievers in 2012, a good functional outcome (mRS 0‐2) was obtained in >40% of the treated patients. In 2018, 61.1% of the patients got a good functional outcome. Conclusions EVT of LVO stroke, performed by general vascular interventional radiologist in close collaboration with diagnostic neuroradiologists and stroke neurologists can achieve technical revascularization results and clinical patient outcomes in line with international recommendations, and the randomized controlled studies performed. This approach may help to introduce EVT in geographical areas where this service is lacking due to the absence of neurointerventional specialists.
- 13 April 2020
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 142 (2) , 169-174
Endovascular thrombectomy at low‐volume centres: A Bayesian solution
Purpose Endovascular treatment (EVT) is traditionally performed by neurointerventional radiologists at tertiary medical centres imposing long transport ways to large vessel occlusion (LVO) stroke patients in rural areas. The purpose of this study is to evaluate the technical and clinical results over time at Stavanger University Hospital, a hospital without neurointerventional expertise, where trained general interventional radiologist perform EVT. Methods All patients with LVO stroke treated with EVT from May 2009 to December 2018 were included in the analysis. Technical outcome was measured by the modified treatment in cerebral ischemia (mTICI) score, functional outcome by the modified Rankin scale (mRS), complications registered. Results 235 patients were treated with EVT. An angiographically good result (mTICI 2b or 3) could be seen in 66.7% of the patients treated the first year. In 2011, the year EVT with stent retrievers was introduced, the recanalization rate rose to 81.8% and from 2014 onwards it was stable around 80%. After introduction of aspiration together with stent retrievers in 2012, a good functional outcome (mRS 0‐2) was obtained in >40% of the treated patients. In 2018, 61.1% of the patients got a good functional outcome. Conclusions EVT of LVO stroke, performed by general vascular interventional radiologist in close collaboration with diagnostic neuroradiologists and stroke neurologists can achieve technical revascularization results and clinical patient outcomes in line with international recommendations, and the randomized controlled studies performed. This approach may help to introduce EVT in geographical areas where this service is lacking due to the absence of neurointerventional specialists.